Abstract
Background: Myopia, commonly referred to as short sightedness is a form of refractive error and is a very common cause of visual disability throughout the world.
 Methods: Hospital based prospective study conducted on 100 patients of Myopia attending to Department of Opthalmolgy.
 Results: There was no significant difference in the age, gender distribution, baseline myopia progression or follow-up duration between patients who used night application compared with daytime atropine. Effectiveness was better with daytime application.
 Conclusion: 1% atropine eye drops were well tolerated and efficacious for the retardation of progressive myopia in Indian eyes. Effectiveness was better with daytime application. Further studies are necessary to assess the role of 1% atropine in the rapid progressors and patients poorly responding to low-dose atropine.
 Keywords: Myopia, Atropine, low dose.
Highlights
Myopia, commonly referred to as short sightedness is a form of refractive error and is a very common cause of visual disability throughout the world
There was no significant difference in the age, gender distribution, baseline myopia progression or follow-up duration between patients who used night application compared with daytime atropine
The prevalence of myopia varies by the country, age and by ethnic group it is a major cause of visual impairment in both the developed and the developing world.[1]
Summary
Commonly referred to as short sightedness is a form of refractive error and is a very common cause of visual disability throughout the world. School myopia commences around 5-15 years of age and tends to stabilize in the late teens and is mainly thought to be idiopathic. The prevalence of myopia varies by the country, age and by ethnic group it is a major cause of visual impairment in both the developed and the developing world.[1] The prevalence of myopia has been reported to be as high as 70-90% in some Asian population with Taiwan reporting a myopic prevalence of 84% among 16-18 - years - old high school students.[2,3]. Three fourth of visual impairment was attributed to refractive errors in the same survey Both concentration and frequency of atropine have been modified to minimize the side effects while trying to maintain the benefits. In 1999 it was suggested that because daily drops of 0.1% and 0.25% atropine were well-tolerated, those concentrations could be used initially to control the progression of myopia in children with rapid progression or in those who tended to have severe or early-onset myopia.[7]
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: International Journal of Medical and Biomedical Studies
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
